{"id":"https://openalex.org/W2012111966","doi":"https://doi.org/10.1089/jop.1989.5.141","title":"Sustained Release of 5-Fluorouracil from Ethylene Acetate Copolymer","display_name":"Sustained Release of 5-Fluorouracil from Ethylene Acetate Copolymer","publication_year":1989,"publication_date":"1989-01-01","ids":{"openalex":"https://openalex.org/W2012111966","doi":"https://doi.org/10.1089/jop.1989.5.141","mag":"2012111966","pmid":"https://pubmed.ncbi.nlm.nih.gov/2754299"},"language":"en","primary_location":{"id":"doi:10.1089/jop.1989.5.141","doi":"https://doi.org/10.1089/jop.1989.5.141","is_oa":false,"landing_page_url":"https://doi.org/10.1089/jop.1989.5.141","pdf_url":null,"source":{"id":"https://openalex.org/S192126995","display_name":"Journal of Ocular Pharmacology and Therapeutics","issn_l":"1080-7683","issn":["1080-7683","1557-7732","8756-3320"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Ocular Pharmacology and Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028261238","display_name":"Richard E. Wyszynski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"RICHARD E. WYSZYNSKI","raw_affiliation_strings":["Veterans Administration Medical Center, Case Western Reserve University, Cleveland, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Veterans Administration Medical Center, Case Western Reserve University, Cleveland, Ohio","institution_ids":["https://openalex.org/I58956616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046150934","display_name":"JEAN B. VAHEY","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"JEAN B. VAHEY","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"LAURI MANNING","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"LAURI MANNING","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091268699","display_name":"William E. Bruner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"WILLIAM E. BRUNER","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113846296","display_name":"Kirk M. Morgan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"KIRK M. MORGAN","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5104978614","display_name":"EDWARD N. BURNEY","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"EDWARD N. BURNEY","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.4659,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.46510152,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"5","issue":"2","first_page":"141","last_page":"146"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10250","display_name":"Glaucoma and retinal disorders","score":0.007199999876320362,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10343","display_name":"Hydrogels: synthesis, properties, applications","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/5-fluorouracil","display_name":"5-fluorouracil","score":0.9980000257492065},{"id":"https://openalex.org/keywords/sustained-release","display_name":"sustained drug release","score":0.8949999809265137},{"id":"https://openalex.org/keywords/ethylene-vinyl-acetate-copolymer","display_name":"ethylene-vinyl acetate copolymer","score":0.9929999709129333},{"id":"https://openalex.org/keywords/glaucoma-filtering-surgery","display_name":"glaucoma filtration surgery","score":0.9010000228881836},{"id":"https://openalex.org/keywords/antifibrotic-agents","display_name":"antifibrotic agents","score":0.6800000071525574},{"id":"https://openalex.org/keywords/drug-reservoir","display_name":"drug reservoir","score":0.6449999809265137},{"id":"https://openalex.org/keywords/fibroblast-proliferation","display_name":"fibroblast proliferation","score":0.6639999747276306},{"id":"https://openalex.org/keywords/scar-formation","display_name":"scar formation","score":0.5519999861717224},{"id":"https://openalex.org/keywords/ocular-drug-delivery","display_name":"ocular drug delivery","score":0.7889999747276306}],"concepts":[{"id":"https://openalex.org/C2780456651","wikidata":"https://www.wikidata.org/wiki/Q238512","display_name":"Fluorouracil","level":3,"score":0.6825011968612671},{"id":"https://openalex.org/C15920480","wikidata":"https://www.wikidata.org/wiki/Q421281","display_name":"Copolymer","level":3,"score":0.6644065380096436},{"id":"https://openalex.org/C2778597550","wikidata":"https://www.wikidata.org/wiki/Q151313","display_name":"Ethylene","level":3,"score":0.49830079078674316},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4598226845264435},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3954462707042694},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3643606901168823},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.2993725538253784},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.24417024850845337},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.22576066851615906},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.21768391132354736},{"id":"https://openalex.org/C521977710","wikidata":"https://www.wikidata.org/wiki/Q81163","display_name":"Polymer","level":2,"score":0.11899787187576294},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.08713236451148987}],"mesh":[{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011145","descriptor_name":"Polyvinyls","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014677","descriptor_name":"Pharmaceutical Vehicles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1089/jop.1989.5.141","doi":"https://doi.org/10.1089/jop.1989.5.141","is_oa":false,"landing_page_url":"https://doi.org/10.1089/jop.1989.5.141","pdf_url":null,"source":{"id":"https://openalex.org/S192126995","display_name":"Journal of Ocular Pharmacology and Therapeutics","issn_l":"1080-7683","issn":["1080-7683","1557-7732","8756-3320"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Ocular Pharmacology and Therapeutics","raw_type":"journal-article"},{"id":"pmid:2754299","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2754299","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of ocular pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":6,"referenced_works":["https://openalex.org/W15357752","https://openalex.org/W76456056","https://openalex.org/W1971963308","https://openalex.org/W1977149291","https://openalex.org/W1989175181","https://openalex.org/W2031585884"],"related_works":["https://openalex.org/W2161198160","https://openalex.org/W4414184987","https://openalex.org/W1994699843","https://openalex.org/W2178137457","https://openalex.org/W2412127602","https://openalex.org/W2345431990","https://openalex.org/W3149375900","https://openalex.org/W2025250317","https://openalex.org/W2076540586","https://openalex.org/W250535304"],"abstract_inverted_index":{"Pharmacologic":[0],"inhibition":[1,18],"of":[2,49,68,80,98,109,117,127],"fibroblast":[3],"proliferation":[4,111],"and":[5,59],"scar":[6],"formation":[7],"remains":[8],"an":[9,124],"important":[10,21],"consideration":[11],"in":[12,22,41,77,103],"many":[13],"ophthalmologic":[14],"surgical":[15],"procedures.":[16],"Such":[17],"is":[19,112],"particularly":[20],"glaucoma":[23,104],"filtration":[24],"surgery.":[25],"A":[26],"sustained":[27,58,96],"release":[28,61,82,97],"system":[29,93],"for":[30,94],"5-fluorouracil":[31],"(5-FU)":[32],"using":[33],"ethylene":[34],"vinyl":[35],"acetate":[36],"copolymer":[37],"(Elvax)":[38],"was":[39,44],"characterized":[40],"vitro.":[42],"5-FU":[43,81,99,128],"incorporated":[45],"into":[46],"Elvax":[47,118],"discs":[48],"4":[50],"mm":[51],"diameter.":[52],"Discs":[53],"were":[54],"coated":[55],"to":[56],"allow":[57],"predictable":[60],"over":[62],"a":[63],"14":[64],"day":[65],"period.":[66],"Alteration":[67],"coatings,":[69],"which":[70,86],"act":[71],"as":[72,88],"rate-controlling":[73],"membranes,":[74],"allowed":[75],"variation":[76],"the":[78,84,89,95,107],"pattern":[79],"from":[83],"core":[85],"acts":[87],"drug":[90],"reservoir.":[91],"This":[92],"may":[100,122],"prove":[101],"valuable":[102],"surgery":[105],"where":[106],"suppression":[108],"cellular":[110],"desired.":[113],"The":[114],"non-inflammatory":[115],"nature":[116],"suggests":[119],"this":[120],"compound":[121],"provide":[123],"alternative":[125],"means":[126],"delivery.":[129]},"counts_by_year":[{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}